<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Cognate BioServices, Inc. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=30379></link><description><![CDATA[Cognate BioServices, Inc. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 16 May 2026 13:18:50 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2018/02/3698601005_20180221134230_8636091670.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Cognate Completes Management Buyout and Raises Growth Capital to Fund Commercial Cellular Therapy Manufacturing Expansion]]></title><link>https://www.newswire.co.kr/newsRead.php?no=864836</link><description><![CDATA[BALTIMORE & MEMPHIS, Tenn.--(Business Wire/Korea Newswire)--Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, announced today it has completed a management buyout (“MBO”) and raised capital from a group of global investment firms including Santa Monica, Calif.-based Tennenbaum Capital Partners, LLC (“TCP”), Medivate Part...]]></description><pubDate>Wed, 21 Feb 2018 13:55:00 +0900</pubDate></item><item><title><![CDATA[코그네이트, 경영자인수 완료 및 상용 줄기세포치료제 생산 확대 위한 성장자본 모집]]></title><link>https://www.newswire.co.kr/newsRead.php?no=864837</link><description><![CDATA[볼티모어/멤피스, 테네시--(Business Wire/뉴스와이어)--세계 줄기세포치료제 시장을 대표하는 의약품 개발생산 위탁기업(CDMO)인 코그네이트 바이오서비스(Cognate BioServices)가 경영자인수(MBO)를 완료하고 캘리포니아 주 산타모니카(Santa Monica) 소재 테넌바움 캐피털 파트너스(Tennenbaum Capital Partners, LLC, 이하 TCP), 서울 소재 메디베이트 파트너스(Medivate Partners) 및 계열사(이하 메디베이트), 국부펀드 등 ...]]></description><pubDate>Wed, 21 Feb 2018 13:55:00 +0900</pubDate></item></channel></rss>